Alzheimers-associated inflammatory alterations mediate tau-associated neurodegeneration in limbic and temporal regions across clinical variants of Alzheimers disease
Patrick Lao,Seonjoo Lee,Daniel Talmasov,Dina Dass,Aubrey Sperling Johnson,Anna Smith,Diana Guzman,Amarachukwu Okafor,Hannah Houlihan,Lauren Heuer,Thairi Sanchez,Samantha Rossano,William Charles Kreisl,Jame M Noble,Yasir Qureshi,Scott Small
DOI: https://doi.org/10.1101/2024.11.01.24316493
2024-11-04
Abstract:Objectives: Microglia surveil and respond to the brain microenvironment, maintaining homeostasis. However, in Alzheimers disease and related dementias (ADRD), microglia may promote pathology. We hypothesized that the AD-associated inflammatory alterations, measured with TSPO PET, would be locally associated with amyloid, tau, and neurodegeneration, and drive key pathways among them.
Methods: Participants (21 controls, 25 individuals with ADRD) from the Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimers Disease study underwent baseline amyloid PET (Florbetaben SUVR), tau PET (MK6240 SUVR), TSPO PET (ER176 SUVR), and structural MRI (gray matter volume). Cognitive assessment and consensus diagnosis (e.g., MCI, AD, PCA, FTD, LATE) were performed at the CUIMC ADRC. We assessed regional colocalization of biomarker elevation in ADRD compared to controls, TSPO associations with ATN biomarkers, and TSPO mediations along key ATN pathways. Sensitivity analyses were performed stratified by amyloid positivity.
Results: Elevated TSPO spatially colocalized with elevated tau (8 regions), elevated amyloid (7 regions), and elevated neurodegeneration (4 regions). Greater TSPO in limbic, temporal, and parietal regions was associated with greater tau (0.8 to 2.3, p<0.03), which survived amyloid and neurodegeneration adjustment in the inferior parietal cortex. TSPO mediated the association between tau and neurodegeneration in limbic and temporal regions (-0.27 to -0.39, p<0.02; 43% to 89% of the total effect), while tau did not mediate the association between TSPO and neurodegeneration. TSPO further mediated the association between amyloid and tau as well as tau across progressive Braak stages, but only in amyloid positive ADRD.
Conclusion: Across ADRD diagnoses that have different underlying brain microenvironments (e.g., pathology/copathology) to which microglia are sensitive, greater microglia density was associated with greater tau burden and mediated tau-associated neurodegeneration. Glia may represent an interesting target for intervention strategies in ADRD-associated tau and neurodegeneration.